FastThread Interference Screws

Arthrex, Inc.50 enrolled

Overview

Surgery using the Arthrex PEEK or Biocomposite FastThread Interference Screw for ACL or PCL (PCL at US sites only, Biocomposite screw PCL only) repair or reconstruction.

The objective of the study is to evaluate the continued safety and effectiveness of the PEEK and Biocomposite FastThread Interference Screws used for Anterior Cruciate Ligament (ACL) and Posterior Cruciate Ligament (PCL) repair or reconstruction (PCL at US sites only, Biocomposite screw PCL only). To assess safety, device-related adverse events will be reported and evaluated over the course of the study. To evaluate effectiveness, patient reported outcomes will be collected at 3 months postoperative, 6 months postoperative, and one year postoperative using the Visual Analogue Scale (VAS) for measuring pain in the affected knee and the Knee Injury and Osteoarthritis Outcome Score (KOOS) as well as Range of Motion (ROM, optional) for measuring knee functionality.

Study Type

OBSERVATIONAL

Enrollment

Conditions

ACL Injury

Interventions

Arthrex FastThread Interference ScrewDEVICE

The Arthrex PEEK and Biocomposite FastThread Interference Screws have a tapered hexalobe design along the entire length of the screw to maximize transfer of torque and reduce screw stripping. The Arthrex PEEK and Biocomposite FastThread Interference Screws have a tapered hexalobe design along the entire length of the screw to maximize transfer of torque and reduce screw stripping

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject requires surgery using the Arthrex PEEK Interference Screw for ACL or PCL (PCL at US sites only) repair or reconstruction or the Arthrex Biocomposite Interference Screw for PCL (PCL at US sites only) repair or reconstruction. * Subject is 18 years of age or over. * Subject is not considered a vulnerable subject (i.e. child, pregnant, nursing, prisoner, or ward of the state). * Subject signed informed consent and is willing and able to comply with all study requirements. Exclusion Criteria: * Current bilateral injury of the ACL or PCL. * Injury of the ACL and PCL in the same knee. * Insufficient quantity or quality of bone. * Blood supply limitations and previous infections which may retard healing. * Foreign-body sensitivity. * Any active infection or blood supply limitations. * Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period. * Subjects that are skeletally immature.

Locations (2)

Anderson Sports Medicine

Bingham Farms, Michigan, United States

RECRUITING

Sportklinik Ravensburg

Ravensburg, Germany

RECRUITING

Outcomes

Primary Outcomes

To assess change in Visual Analogue Scale (VAS)

Patient reported pain scale 0-10 point scale (0 min, 10 max)

Time frame: preoperatively, 3 months, 6 months and 12 months post operative

To assess change in Knee Injury and Osteoarthritis Outcome Score (KOOS)

Patient reported outcome assessment. The interval score ranges from 0 to 100, (where 0 represents total knee disability and 100 represents perfect knee health)

Time frame: preoperatively, 3 months, 6 months and 12 months post operative

To assess change in Range of Motion (ROM)

Measuring knee functionality. (Flexion 0 to 130 degrees Extension 120 to 0 degrees

Time frame: preoperatively, 3 months, 6 months and 12 months post operative

Central Contacts

Samantha Martino

CONTACT

800.933.7001 samantha.martino@arthrex.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.